CTTH - CTT Pharma Will Utilize Patented Technology for Additional Oral Products
(TheNewswire)
Tampa, Florida, United States – The Newswire – November 14, 2022– CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) can and will utilizeour patents for more deliverables including but not limited to gummiesand chewing gum. CTT believes we can help companies with theirexisting products, by incorporating our fast delivery system. CTTPharma will start engaging companies with existing productsimmediately and look to partner with them for product research anddevelopment.
Ryan Khouri, CEO of CTT Pharma stated, CTT's ability to use ourtechnology in other deliverables will allow us to expand our reachbeyond companies looking to manufacture our dissolvable strips. Thusgiving CTT the ability to communicate with more companies and workwith them to make their current and future products quicker, whichwould give them an advantage over their competitors. Expanding ourpatented technology into additional products can also help CTT createpartnerships, generate revenue, and unlock shareholder value.
CTT will keep shareholders updated on further developments.
Ryan Khouri – 813-606-0060
Copyright (c) 2022 TheNewswire - All rights reserved.